Skip to main content

Teresa Soriano Sánchez

Institutions of which they are part

Senior researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Teresa Soriano Sánchez

Institutions of which they are part

Senior researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Caracterización de perfiles proteómicos predictivos de hepatotoxicidad asociada a medicamentos antituberculosos: un estudio exploratorio

IP: -
Collaborators: Francesc Canals Suris, Maria Buti Ferret, Xavier Martínez Gómez, Núria Saborit Braceros, Teresa Soriano Sánchez, Israel Molina Romero, Eulàlia Pérez Esquirol, Mònica Sabaté Gallego, Maria Urquizu Padilla, Núria Colome Calls
Funding agency: Instituto de Salud Carlos III
Funding: 150645
Reference: EC08/00250
Duration: 01/01/2009 - 31/12/2012

Ensayo clínico, aleatorizado, controlado, paralelo, doble ciego, para evaluar eficacia-seguridad de alteplasa vs uroquinasa intrapleurales como tratamiento del derrame paraneumónico complicado complejo y empiema

IP: Maria Carmen Aleman Llanso
Collaborators: Ana Vázquez Suárez, J. Bruno Montoro Ronsano, José Alegre Martin, Tomás Fernández de Sevilla Ribosa, María Deu Martín, Jordi Andreu Soriano, Teresa Soriano Sánchez, Pilar Suñe Martin, Eva Ruiz Ruiz
Funding agency: Instituto de Salud Carlos III
Funding: 82885
Reference: EC07/90479
Duration: 01/11/2007 - 30/06/2011

Ensayo clínico, aleatorizado, controlado, paralelo, doble ciego, para evaluar eficacia-seguridad de alteplasa vs uroquinasa intrapleurales como tratamiento del derrame parneumónico complicado complejo y empiema

IP: Maria Carmen Aleman Llanso
Collaborators: Ana Vázquez Suárez, J. Bruno Montoro Ronsano, Tomás Fernández de Sevilla Ribosa, Jordi Andreu Soriano, Teresa Soriano Sánchez, Pilar Suñe Martin
Funding agency: Instituto de Salud Carlos III
Funding: 20700
Reference: PI040546
Duration: 01/01/2005 - 28/11/2007

Estudio de la angiogénesis y la respuesta inflamatoria en la patogenia de las complicaciones de los derrames pleurales bacterianos.

IP: José Alegre Martin
Collaborators: Tomás Fernández de Sevilla Ribosa, Lluis Armadans Gil, Jordi Andreu Soriano, Teresa Soriano Sánchez, Maria Carmen Aleman Llanso, Eva Ruiz Ruiz
Funding agency: Instituto de Salud Carlos III
Funding: 23138.97
Reference: 01/1408
Duration: 17/07/2001 - 31/12/2002

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

Related professionals

Lucas Regis Plácido

Lucas Regis Plácido

Postdoctoral researcher
Biomedical Research in Urology
Read more
Miriam Calles Bastande

Miriam Calles Bastande

Research technician
Gene Therapy at Nervous System
Read more
Alba Márquez Gallego

Alba Márquez Gallego

Research technician
Cardiovascular Diseases
Read more
Alicia Fresno González

Alicia Fresno González

Administration and Management
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.